Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05378763
Title A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations (PINNACLE)
Recruitment Suspended
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Spectrum Pharmaceuticals, Inc
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST